113 related articles for article (PubMed ID: 28626084)
1. Optimization of
Santos C; Azuara D; Garcia-Carbonero R; Alfonso PG; Carrato A; Elez ME; Gomez A; Losa F; Montagut C; Massuti B; Navarro V; Varela M; Lopez-Doriga A; Moreno V; Valladares M; Manzano JL; Vieitez JM; Aranda E; Sanjuan X; Tabernero J; Capella G; Salazar R
Mol Cancer Ther; 2017 Sep; 16(9):1999-2007. PubMed ID: 28626084
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment.
Morelli MP; Overman MJ; Dasari A; Kazmi SMA; Mazard T; Vilar E; Morris VK; Lee MS; Herron D; Eng C; Morris J; Kee BK; Janku F; Deaton FL; Garrett C; Maru D; Diehl F; Angenendt P; Kopetz S
Ann Oncol; 2015 Apr; 26(4):731-736. PubMed ID: 25628445
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.
Montagut C; Argilés G; Ciardiello F; Poulsen TT; Dienstmann R; Kragh M; Kopetz S; Lindsted T; Ding C; Vidal J; Clausell-Tormos J; Siravegna G; Sánchez-Martín FJ; Koefoed K; Pedersen MW; Grandal MM; Dvorkin M; Wyrwicz L; Rovira A; Cubillo A; Salazar R; Desseigne F; Nadal C; Albanell J; Zagonel V; Siena S; Fumi G; Rospo G; Nadler P; Horak ID; Bardelli A; Tabernero J
JAMA Oncol; 2018 Apr; 4(4):e175245. PubMed ID: 29423521
[TBL] [Abstract][Full Text] [Related]
5. Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.
Ros J; Matito J; Villacampa G; Comas R; Garcia A; Martini G; Baraibar I; Saoudi N; Salvà F; Martin Á; Antista M; Toledo R; Martinelli E; Pietrantonio F; Boccaccino A; Cremolini C; Dientsmann R; Tabernero J; Vivancos A; Elez E
Ann Oncol; 2023 Jun; 34(6):543-552. PubMed ID: 36921693
[TBL] [Abstract][Full Text] [Related]
6. Clinical Validation of Plasma-Based Genotyping for
Aoki Y; Nakamura Y; Denda T; Ohta T; Esaki T; Shiozawa M; Yamaguchi K; Yamazaki K; Sunakawa Y; Kato T; Okano N; Taniguchi H; Sato T; Oki E; Nishina T; Komatsu Y; Matsuhashi N; Goto M; Yasui H; Ohtsubo K; Moriwaki T; Takahashi N; Horita Y; Boku S; Wakabayashi M; Ikeno T; Mitani R; Yuasa M; Yoshino T
JCO Precis Oncol; 2023 Jun; 7():e2200688. PubMed ID: 37343204
[TBL] [Abstract][Full Text] [Related]
7. HER2-Positive Metastatic Colorectal Cancer.
Robinson HR; Messersmith WA; Lentz RW
Curr Treat Options Oncol; 2024 May; 25(5):585-604. PubMed ID: 38539034
[TBL] [Abstract][Full Text] [Related]
8. Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA).
Di Nardo P; Basile D; Siciliano A; Pelizzari G; Corvaja C; Buriolla S; Ongaro E; Maria Grazia D; Garattini SK; Foltran L; Guardascione M; Casagrande M; Buonadonna A; Prantera T; Aprile G; Puglisi F
Dig Liver Dis; 2024 May; 56(5):786-794. PubMed ID: 37586908
[TBL] [Abstract][Full Text] [Related]
9. Biomarker-driven and molecular targeted therapies for colorectal cancers.
Schirripa M; Cohen SA; Battaglin F; Lenz HJ
Semin Oncol; 2018 Jun; 45(3):124-132. PubMed ID: 30262397
[TBL] [Abstract][Full Text] [Related]
10. Predicting response to EGFR inhibitors in metastatic colorectal cancer: current practice and future directions.
Shankaran V; Obel J; Benson AB
Oncologist; 2010; 15(2):157-67. PubMed ID: 20133499
[TBL] [Abstract][Full Text] [Related]
11. BRAF-Directed Therapy in Metastatic Colorectal Cancer.
Korphaisarn K; Kopetz S
Cancer J; 2016; 22(3):175-8. PubMed ID: 27341594
[TBL] [Abstract][Full Text] [Related]
12. Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma.
Thomsen CB; Hansen TF; Andersen RF; Lindebjerg J; Jensen LH; Jakobsen A
J Exp Clin Cancer Res; 2018 Mar; 37(1):55. PubMed ID: 29530101
[TBL] [Abstract][Full Text] [Related]
13. The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon Cancers.
Kunt N; Araz M; Yildirim MS; Findik S; Kocak MZ; Eryilmaz MK; Artac M
J Gastrointest Cancer; 2023 Dec; 54(4):1316-1321. PubMed ID: 37191843
[TBL] [Abstract][Full Text] [Related]
14. The Developing Role of Anti-Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal Cancer.
Ursem C; Venook AP
Oncology (Williston Park); 2017 Nov; 31(11):785-8, 802. PubMed ID: 29179247
[TBL] [Abstract][Full Text] [Related]
15. Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients.
Muendlein A; Geiger K; Heinzle C; Gaenger S; Winder T; Severgnini L; Reimann P; Brandtner EM; Leiherer A; Drexel H; Decker T; Nonnenbroich C; Dechow T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6435-6444. PubMed ID: 36763171
[TBL] [Abstract][Full Text] [Related]
16. CYTOPLASMIC-MEMBRANE EGFR PREDICTS EXPANDED RAS MUTATION STATUS IN COLORECTAL CARCINOMAS?
Pinto TDA; Alves TDDN; Pinto SA; Oliveira EC
Arq Bras Cir Dig; 2021; 34(1):e1574. PubMed ID: 34133521
[TBL] [Abstract][Full Text] [Related]
17. Targeting
Sundar R; Hong DS; Kopetz S; Yap TA
Cancer Discov; 2017 Jun; 7(6):558-560. PubMed ID: 28576843
[TBL] [Abstract][Full Text] [Related]
18. Predictive and Prognostic Biomarkers for Patients Treated with Anti-EGFR Agents in Lung Cancer: A Systemic Review and Meta-Analysis.
Wang Y; Qu X; Shen HC; Wang K; Liu Q; Du JJ
Asian Pac J Cancer Prev; 2015; 16(11):4759-68. PubMed ID: 26107237
[TBL] [Abstract][Full Text] [Related]
19. BRAF-mutated metastatic colorectal cancer between past and future.
Cremolini C; Di Maio M; Petrelli F; Berenato R; Loupakis F; Pietrantonio F
Br J Cancer; 2015 Dec; 113(11):1634-5. PubMed ID: 26355234
[No Abstract] [Full Text] [Related]
20. Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis.
Rumpold H; Niedersüß-Beke D; Heiler C; Falch D; Wundsam HV; Metz-Gercek S; Piringer G; Thaler J
BMC Cancer; 2020 Nov; 20(1):1149. PubMed ID: 33238958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
